# G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes

> **NCT03439072** · PHASE3 · COMPLETED · sponsor: **Xeris Pharmaceuticals** · enrollment: 81 (actual)

## Conditions studied

- Insulin Hypoglycemia
- Type 1 Diabetes Mellitus
- Severe Hypoglycemia

## Interventions

- **DRUG:** G-Pen
- **DRUG:** Lilly Glucagon

## Key facts

- **NCT ID:** NCT03439072
- **Lead sponsor:** Xeris Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-23
- **Primary completion:** 2018-04-18
- **Final completion:** 2018-05-03
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2020-02-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03439072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03439072, "G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03439072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*